Home Updates Press Mr. Suresh Vazirani felicitated by Dr. Harsh Vardhan - Hon’ble Minister of Science & Technology for “Pioneer for Make in India Concept” initiative
Mr. Suresh Vazirani felicitated by Dr. Harsh Vardhan - Hon’ble Minister of Science & Technology for “Pioneer for Make in India Concept” initiative
Date: 20 December , 2015 in India , International

Mumbai, 20th December, 2015 : At the recently held Association of Practising Pathologists (APP) National Pathcon & Lab Expo 2015, Mr. Suresh Vazirani, Chairman and Managing Director - Transasia Bio-Medicals Ltd., was felicitated and commended for Transasia’s ‘Pioneer of Make in India Concept’ initiative. This was bestowed by the Honorable Minister of Science & Technology and Earth Sciences, Government of India.

Dr. Harsh Vardhan, the Hon’ble Minister of India, acknowledged the role of the APP in the areas of Continuing Medical Education and Quality Assurance. He further appreciated their efforts in organizing CME activities and proficiency testing programmes, thereby helping a large number of medical laboratories in improving their services, ultimately benefitting the common man.

The Association of Practising Pathologists founded in the year 2001, started with a ‘dream and mission’ of achieving high quality in all the diagnostic laboratories. It has been organizing its annual event in the form of PATHCON every year. This was the 2nd National Conference and was held at India Habitat Centre, New Delhi. The conference was attended by over 500 eminent and well-known doctors and practicing pathologists from various parts of Northern India.

Transasia Bio-Medicals Ltd. founded by Mr. Suresh Vazirani, a true visionary, has led the organization for over three decades to become the largest Indian In-Vitro Diagnostic Company. It has pioneered the ‘Make in India’ initiative in 1991 with the indigenous manufacture of lab equipments and analyzers. Transasia now has three state-of-the-art manufacturing facilities in India for fully automatic random access analyzers, Elisa readers, HPLC system for HbA1c among other advanced products.

With over 45,000 installations, dedicated service engineers, sales and marketing team and a vast network of distributors PAN India, Transasia caters to segments like Biochemistry, Hematology, Coagulation, ESR, Immunology, Urinalysis, Critical Care, Molecular Diagnostics, Diabetes Management and Microbiology.

With 10 overseas subsidiaries it serves millions in over 100 countries. The ERBA Transasia Group has spread its footprint across the world through its acquisitions – ERBA Germany, ERBA Czech Republic, ERBA Russia, ERBA Turkey, ERBA France, ERBA Diagnostics (USA), Diamedix

(USA), Delta Biologicals (Italy), ImmunoVision (USA), JAS Diagnostics Inc. (USA) ,Drew Scientific (USA) and Erba Molecular (UK).

About Transasia Bio-Medicals Ltd.

Incepted in the year 1979, Transasia Bio-Medicals Ltd., is headquartered in Mumbai, India. It is recognized as India’s Largest In-vitro Diagnostic Company and offers solutions and products in Biochemistry, Hematology, Coagulation, ESR, Immunology, Urinalysis, Critical Care, Diabetes Management, Microbiology and Molecular Diagnostics. Infact, Transasia is the first Indian company to manufacture and export sophisticated, state-of-the-art blood analyzers and reagents.

Transasia is a part of the global Erba Diagnostics Mannheim GmbH Group. The Erba Transasia Group has spread its footprint across USA, UK, Europe, Turkey and Eastern Europe, Russia and France, by means of various acquisitions – Erba Germany, Erba Czech Republic, Erba Russia, Erba Turkey, Erba France, Erba Diagnostics (USA), Erba Molecular (UK), Diamedix (USA), Delta Biologicals (Italy), ImmunoVision (USA), JAS Diagnostics Inc. (USA) and Drew Scientific (USA). Today, the Erba Transasia Group serves millions across 100 countries.

Recently, the Erba - Transasia Group has added another feather to its cap by acquiring Lumora, a UK based patented molecular technology company. This makes the Group, one of the selected few global companies with its own patented technology for molecular testing.

Transasia manufactures and markets equipment and reagents, with an impressive install base of above 50,000 equipments across India. The vast network of more than 180 service engineers, 350+ Sales and Marketing Team, 16 zonal offices, and 350+ Distributors allows us to reach out to customers across the length and breadth of the country. Its foray into indigenous research has resulted in development of state of the art products and technologies, enabling Transasia’s deliverables to be synonymous with the best in the world.

Alliances with international partners like Sysmex Corporation (Japan), Medica (USA) and Diesse (Italy) have ensured that cutting edge technology and solutions is brought to India. Transasia markets, services and supports the Sysmex products and solutions in India.

Transasia’s commitment to healthcare has been recognized by various awards and accolades, the latest one from the World Economic Forum which conferred the organization with ‘Global Growth Company Award, 2014’, ‘Most Indigenous Medical Equipment Devices Company’, ‘Pioneer for the Make in India Concept’ Award, by the Hon’ble Minister of Science & Technology & Earth Sciences, Government of India and recently was bestowed with the ‘Maker in India’ Award 2015.

With a vision of being recognized as a ‘local for global’ organization, Transasia continues to provide doctors and patients with reliable, affordable and innovative Medical Diagnostic Systems.

Subscribe here
Stay Connected
Mallaustrasse 69-73 68219
Mannheim, Germany
© 2016-2017, Erba Mannheim All Rights Reserved
Select Country